The new treatment, called tumor-infiltrating lymphocyte therapy, or TIL therapy, uses a patient’s own immune cells found inside their tumors.

May 21 () - Moderna and Merck's combination therapy for skin cancer helped reduce risk of cancer spreading to another ‌part ...

For the past 15 years or so, a class of drugs called immune checkpoint inhibitors have been used to treat melanoma – the most ...

It's feeding time for the macrophages – and for the first time ever, science has a front-row seat. Thanks to some clever ...

A new personalized skin cancer treatment is showing success in preventing the return of high-risk melanoma. Five-year study results were announced on Tuesday by pharmaceutical companies Moderna Inc ...

The FDA rejected the promising skin cancer drug RP1 twice, leaving many puzzled and worried about what this means for other drug approvals ...

Melanoma is among the most preventable skin cancers when found early, yet it remains the skin cancer most likely to spread ...

OU Health Stephenson Cancer Center told News 9 on Sunday that it is the only site in Oklahoma that offers a new cell therapy to treat advanced melanoma. OU Health Stephenson Cancer Center told News 9 ...

Immunotherapy uses the power of your immune system to fight your cancer. One type of immunotherapy is called an immune checkpoint inhibitor. Your immune system has built-in checkpoints that keep it ...

Many patients at Fred Hutch Cancer Center receive promising therapies by taking part in clinical trials. These research studies are done by researchers from Fred Hutch and UW Medicine. They test new ...

The U.S. Food and Drug Administration's decision to withhold approval of a new skin cancer treatment fell like a hammer on ...